Quantum Biopharma (QNTM) Enterprise Value (2018 - 2025)
Quantum Biopharma's Enterprise Value history spans 8 years, with the latest figure at -$4.2 million for Q4 2025.
- On a quarterly basis, Enterprise Value rose 49.19% to -$4.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.2 million, a 49.19% increase, with the full-year FY2025 number at -$4.2 million, up 49.19% from a year prior.
- Enterprise Value hit -$4.2 million in Q4 2025 for Quantum Biopharma, up from -$6.7 million in the prior quarter.
- Over the last five years, Enterprise Value for QNTM hit a ceiling of -$2.9 million in Q1 2024 and a floor of -$40.8 million in Q3 2021.
- Historically, Enterprise Value has averaged -$16.2 million across 5 years, with a median of -$8.2 million in 2024.
- Biggest five-year swings in Enterprise Value: tumbled 245.78% in 2021 and later soared 87.34% in 2023.
- Tracing QNTM's Enterprise Value over 5 years: stood at -$35.4 million in 2021, then skyrocketed by 52.06% to -$17.0 million in 2022, then skyrocketed by 73.72% to -$4.5 million in 2023, then crashed by 84.59% to -$8.2 million in 2024, then skyrocketed by 49.19% to -$4.2 million in 2025.
- Business Quant data shows Enterprise Value for QNTM at -$4.2 million in Q4 2025, -$6.7 million in Q3 2025, and -$6.7 million in Q2 2025.